Authors | |
Abstract |
The effective altruism movement aims to save lives in the most cost-effective ways. In the future, technology will allow radical life extension, and anyone who survives until that time will gain potentially indefinite life extension. Fighting aging now increases the number of people who will survive until radical life extension becomes possible. We suggest a simple model, where radical life extension is achieved in 2100, the human population is 10 billion, and life expectancy is increased by simple geroprotectors like metformin or nicotinamide mononucleotide by three more years on average, so an additional 750 million people survive until “immortality”. The cost of clinical trials to prove that metformin is a real geroprotector is $65 million. In this simplified case, the price of a life saved is around eight cents, 10 000 times cheaper than saving a life from malaria by providing bed nets. However, fighting aging should not be done in place of fighting existential risks, as they are complementary causes.
|
Keywords | aging life extension metformin effective altruism clinical trials |
Categories | (categorize this paper) |
Options |
![]() ![]() ![]() |
Download options
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
The Ethics of Anti-Aging Clinical Trials.Parker Crutchfield - 2018 - Science and Engineering Ethics 24 (2):441-453.
Artificial Intelligence in Life Extension: From Deep Learning to Superintelligence.Alexey Turchin, Denkenberger David, Zhila Alice, Markov Sergey & Batin Mikhail - 2017 - Informatica 41:401.
End of Life Pediatric Research: What About the Ethics? [REVIEW]Danielle Laudy - 2009 - Journal of Academic Ethics 7 (1-2):87-91.
Life Extension Research: Health, Illness, and Death.Leigh Turner - 2004 - Health Care Analysis 12 (2):117-129.
Life Extension Research: An Analysis of Contemporary Biological Theories and Ethical Issues. [REVIEW]Jennifer Marshall - 2005 - Medicine, Health Care and Philosophy 9 (1):87-96.
Immortality, Human Nature, the Value of Life and the Value of Life Extension.Steven Horrobin - 2006 - Bioethics 20 (6):279–292.
Life Span Extension Research and Public Debate: Societal Considerations.Aubrey D. N. J. de Grey - 2007 - Law and Ethics of Human Rights 1 (1).
Life in Overabundance: Agar on Life-Extension and the Fear of Death.Aveek Bhattacharya & Robert Mark Simpson - 2014 - Ethical Theory and Moral Practice 17 (2):223-236.
Building a Postwork Utopia: Technological Unemployment, Life Extension and the Future of Human Flourishing.John Danaher - 2017 - In Kevin Lagrandeur & James Hughes (eds.), Surviving the Machine Age. Palgrave-MacMillan. pp. 63-82.
Aging and the Aged: Theories of Aging and Life Extension.G. R. Martin & G. T. Baker - forthcoming - Encyclopedia of Bioethics, New York: Macmillan.
Making the Case for Human Life Extension: Personal Arguments.John Schloendorn - 2006 - Bioethics 20 (4):191–202.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is It Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
Analytics
Added to PP index
2018-03-20
Total views
321 ( #31,948 of 2,498,523 )
Recent downloads (6 months)
29 ( #30,251 of 2,498,523 )
2018-03-20
Total views
321 ( #31,948 of 2,498,523 )
Recent downloads (6 months)
29 ( #30,251 of 2,498,523 )
How can I increase my downloads?
Downloads